Jennifer Villwock, MD
Otolaryngology · Kansas City, KSNPI 1073804902
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,800 of the $25,993 with a category attached, or 83.9%. GSK accounts for 84.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $14,095 and has fallen 81.2% since, to $2,644 in 2025. Among otolaryngology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $1528.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$22K
- Medtronic$3K
- AstraZeneca$333
- Regeneron Healthcare Solutions, Inc.$197
- Sanofi$52
- Optinose US, Inc.$37
- plus $17 from 1 others
What the payments were for
- Consulting fees$21,80084%
- Speaking & faculty fees$3,55014%
- Food & beverage$6432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 6 | $22,012 |
| Medtronic | 3 | $3,344 |
| AstraZeneca | 2 | $333 |
| Regeneron Healthcare Solutions, Inc. | 2 | $197 |
| Sanofi | 2 | $52 |
| Optinose US, Inc. | 1 | $37 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUADCUT$2,200
- STRAIGHTSHOT$1,100
- TEZSPIRE$250
How this compares
$25,993 in reported general payments places this provider in the 95th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 42 | $1,737 |
| Ipratropium Bromide | 30 | $816 |
| Fluticasone Propionate | 25 | $493 |
| Mupirocin | 14 | $133 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kansas City
- Hinrich StaeckerKansas City$499K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
- Andres BurKansas City$10K
- Christopher LarsenKansas City$8K
- John KrietKansas City$6K
- Justin BondKansas City$4K
- Mohammad Ameen AmanianKansas City$3K
- Frantzlee LacreteKansas City$3K
- Jennifer DieboltKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.